Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 265 | 250 | 314 | 366 | 371 |
| Marketable Securities | 423 | 478 | 470 | 493 | 607 |
| Receivables | 14 | 13 | 17 | 16 | 27 |
| Inventories | 19 | 21 | 7 | 8 | 12 |
| TOTAL | $720 | $763 | $808 | $883 | $1,016 |
| Non-Current Assets | |||||
| PPE Net | 277 | 279 | 288 | 313 | 316 |
| Investments And Advances | 2 | 2 | 12 | 12 | 12 |
| Other Non-Current Assets | 14 | 17 | 20 | 24 | 0 |
| TOTAL | $293 | $298 | $319 | $349 | $328 |
| Total Assets | $1,013 | $1,060 | $1,127 | $1,231 | $1,344 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7 | 15 | 17 | 19 | 8 |
| TOTAL | $38 | $47 | $47 | $52 | $27 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4 | 6 | 9 | 12 | 0 |
| TOTAL | $44 | $44 | $47 | $57 | $54 |
| Total Liabilities | $82 | $91 | $94 | $109 | $81 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 856 | 856 | 856 | 856 | 911 |
| Common Shares | 6,485 | 6,485 | 6,485 | 6,485 | 6,555 |
| Retained earnings | -508 | -448 | -381 | -333 | -241 |
| Other shareholders' equity | -33 | -55 | -59 | -17 | -38 |
| TOTAL | $932 | $970 | $1,033 | $1,122 | $1,264 |
| Total Liabilities And Equity | $1,013 | $1,060 | $1,127 | $1,231 | $1,344 |